Improving patient compliance requires drug delivery systems that are both effective and less invasive. Our efforts focus on biomaterial-based formulations, nanocarriers, and peptide-based delivery systems that facilitate the precise transport of therapeutic agents through intranasal, transdermal, and oral routes. These advanced systems leverage cutting-edge materials science and molecular engineering to improve bioavailability, enhance drug stability, and enable controlled or sustained release, thereby ensuring optimal therapeutic outcomes.